3D margin assessment predicts local tumor progression after ablation of colorectal cancer liver metastases

References

• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–968.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes—a 10-year experience at a single center. Radiology. 2016;278(2):601–611.
   PubMed Web of Science ®Google Scholar
• Vasiniotis Kamarinos N, Sofocleous CT. Imaging and image-guided thermal ablation for oligometastatic colorectal cancer liver disease. Cancer J. 2020;26(2):124–128.
   PubMed Web of Science ®Google Scholar
• Tinguely P, Dal G, Bottai M, et al. Microwave ablation versus resection for colorectal cancer liver metastases – a propensity score analysis from a population-based nationwide registry. Eur J Surg Oncol. 2020;46(3):476–485.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation. Ann Surg. 2005;242(2):158–171.
   PubMed Web of Science ®Google Scholar
• Han K, Kim JH, Yang SG, et al. A single-center retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases. Radiology. 2021;298(1):212–218.
   PubMed Web of Science ®Google Scholar
• Keil S, Bruners P, Schiffl K, et al. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Cardiovasc Intervent Radiol. 2010;33(2):297–306.
   PubMed Web of Science ®Google Scholar
• Kurilova I, Bendet A, Petre EN, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clinical Colorectal Cancer. 2021;20(2):e82–e95.
   PubMed Web of Science ®Google Scholar
• Odisio BC, Yamashita S, Huang SY, et al. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017;104(6):760–768.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28(7):2727–2734.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268–275.
   PubMed Web of Science ®Google Scholar
• Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705.
   PubMed Web of Science ®Google Scholar
• Tani S, Tatli S, Hata N, et al. Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map. Int J Comput Assist Radiol Surg. 2016;11(6):1133–1142.
   PubMed Web of Science ®Google Scholar
• Sandu RM, Paolucci I, Ruiter SJS, et al. Volumetric quantitative ablation margins for assessment of ablation completeness in thermal ablation of liver tumors. Front Oncol. 2021;11:623098.
   PubMed Web of Science ®Google Scholar
• Laimer G, Jaschke N, Schullian P, et al. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases. Eur Radiol. 2021;31(9):6489–6499.
   PubMed Web of Science ®Google Scholar
• Sakakibara M, Ohkawa K, Katayama K, et al. Three-Dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy. AJR Am J Roentgenol. 2014;202(5):W487–W95.
   PubMed Web of Science ®Google Scholar
• Shin S, Lee JM, Kim KW, et al. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. AJR Am J Roentgenol. 2014;203(1):70–77.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Ryan ER, Sofocleous CT, Schöder H, et al. Split-Dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology. 2013;268(1):288–295.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Inoue Y, Komeda K, et al. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis. BMC Surg. 2010;10(1):27.
   PubMed Web of Science ®Google Scholar
• Cassinotto C, Denys A, Gay F, et al. Radiofrequency ablation of liver tumors: no difference in the ablation zone volume between cirrhotic and healthy liver. Cardiovasc Intervent Radiol. 2018;41(6):905–911.
   PubMed Web of Science ®Google Scholar
• Anderson BM, Lin YM, Lin EY, et al. A novel use of biomechanical model-based deformable image registration (DIR) for assessing colorectal liver metastases ablation outcomes. Med Phys. 2021;48(10):6226–6236.
   PubMed Web of Science ®Google Scholar
• Solbiati M, Muglia R, Goldberg SN, et al. A novel software platform for volumetric assessment of ablation completeness. international journal of hyperthermia: the official journal of European society for hyperthermic oncology. North American Hyperthermia Group. 2019;36(1):336–343.
   Web of Science ®Google Scholar
• Sotirchos VS, Fujisawa S, Vakiani E, et al. Fluorescent tissue assessment of colorectal cancer liver metastases ablation zone: a potential real-time biomarker of complete tumor ablation. Ann Surg Oncol. 2019;26(6):1833–1840.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
   PubMed Web of Science ®Google Scholar
• Vasiniotis Kamarinos N, Vakiani E, Fujisawa S, et al. Immunofluorescence assay of ablated colorectal liver metastases: the frozen section of image-guided tumor ablation? J Vasc Interv Radiol. 2022;33(3):308–315.e1.
   PubMed Web of Science ®Google Scholar
• Vasiniotis Kamarinos N, Vakiani E, Gonen M, et al. Biopsy and margins optimize outcomes after thermal ablation of colorectal liver metastases. Cancers. 2022;14(3):693.
   PubMed Web of Science ®Google Scholar